Skip to main content

Table 4 Site of relapse of LSCLC patients receiving chemotherapy and IMRT

From: Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy

Characteristic Arm without CTV n (%) Arm with CTV n (%)
No. of eligible patients 54(100) 35(100)
Relapse site   
  Local- relapse # 9(16.7) 6(17.1)
  In-field 6(11.1) 4(11.3)
  In-margin 2(3.7) 1(2.9)
  Out-of-field 1(1.9) 1(2.9)
  Distant metastasis* 23(42.6) 18(51.4)
  Distant alone 17(31.5) 13(37.1)
  Local + distant 6(11.1) 5(14.3)
Metastasis sites   
  Brain 11(20.4) 7(20.0)
  Bone 8(14.8) 6(17.1)
  Liver 8(14.8) 3(8.6)
  Lung 4(7.4) 2(5.7)
  Adrenal gland 3(5.6) 1(2.9)
  Peritoneum LN 2(3.7) 3(8.6)
  1. # p = 0.586 *p = 0.274.